Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Raptor mediates the selective inhibitory effect of cardamonin on RRAGC-mutant B cell lymphoma

Fig. 1

Viability of SUDHL-4 and OCI-Ly7 cells treated with inhibitory cardamonin. SUDHL-4 (A) and OCI-Ly7 (B) cells were treated with the indicated concentrations of cardamonin for 24 and 48 h. Cell viability was determined by CCK-8 assay. Data are presented as mean ± SD (n = 3). *p < 0.05, **p < 0.01 compared with the control; ##p < 0.01 compared at 24 h

Back to article page